Adaptive Biotechnologies to Report Second Quarter 2024 Financial Results on August 1, 2024

Company Overview - Adaptive Biotechnologies is a commercial-stage biotechnology company focused on leveraging the adaptive immune system for disease diagnosis and treatment [2] - The company aims to decode the adaptive immune system to fully utilize its diagnostic and therapeutic capabilities [2] - Adaptive Biotechnologies operates in two main business areas: Minimal Residual Disease (MRD) and Immune Medicine, developing clinical diagnostics and partnering with biopharmaceutical companies [2] Financial Reporting - The company will report its financial results for the second quarter of 2024 after market close on August 1, 2024 [1] - A conference call will be held at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss the results [1] - The live audio of the webcast will be available on the company's website and archived for replay within 24 hours [1]